Hypoaesthesia
also: Hypoesthesia
72 drugs40,113 FAERS reportsMedDRA PT
GET
/api/v1/reaction/hypoaesthesiaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D006987
Absent or reduced sensitivity to cutaneous stimulation.
Source: U.S. National Library of Medicine — MeSH (Hypesthesia)
Drugs reporting Hypoaesthesia (72)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Tetrachloroaurate150%
- 2Triclosan18136%
- 3Gadoxetate15335%
- 4Medronate117%
- 5Levomilnacipran1849.8%
- 6Botulinum Toxin Type A1,0548.8%
- 7Eugenol28.0%
- 8Trisodium Citrate5317.7%
- 9Gadodiamide2587.7%
- 10Teriflunomide3,1707.1%
- 11Calcium Citrate26.9%
- 12Gadobenate2565.9%
- 13Phentolamine95.8%
- 14Levamlodipine75.8%
- 15Articaine435.6%
- 16Tetracycline1015.5%
- 17Phendimetrazine35.3%
- 18Iodoquinol25.3%
- 19Aluminum Acetate25.0%
- 20Rutin44.9%
- 21Dichlorphenamide804.9%
- 22Phosphorus4784.9%
- 23Amifampridine1324.8%
- 24Dordaviprone24.7%
- 25Penciclovir164.5%
- 26Fingolimod3,8044.4%
- 27Ofatumumab1,3794.3%
- 28Cefaclor634.2%
- 29Nelarabine394.1%
- 30Triamcinolone1,2464.1%
- 31Diethylpropion54.0%
- 32Tretinoin3373.9%
- 33Eplontersen63.8%
- 34Chloroprocaine23.7%
- 35Bupivacaine6113.7%
- 36Interferon Beta-1b6733.5%
- 37Siponimod3083.5%
- 38Inebilizumab183.5%
- 39Ziconotide833.4%
- 40Satralizumab533.4%
- 41Hyaluronidase3223.4%
- 42Ropivacaine743.2%
- 43Benznidazole33.2%
- 44Colloidal Oatmeal83.2%
- 45Ponesimod103.1%
- 46Doconexent43.1%
- 47Natalizumab5,4183.0%
- 48Tinidazole133.0%
- 49Glatiramer1,8413.0%
- 50Interferon Beta-1a5,5572.9%
- 51Ergotamine102.9%
- 52Hekla Lava142.8%
- 53Dalfampridine2,0012.8%
- 54Erenumab1,4852.8%
- 55Suzetrigine262.7%
- 56Baclofen2,3742.7%
- 57Diflorasone52.7%
- 58Hydrogen242.7%
- 59Capsaicin1012.6%
- 60Ocrelizumab1,6022.6%
- 61Patisiran732.6%
- 62Gadoterate Meglumine932.6%
- 63Lasmiditan292.6%
- 64Diroximel Fumarate2942.6%
- 65Mepivacaine272.4%
- 66Dimethyl Fumarate2,9482.4%
- 67Delafloxacin52.1%
- 68Phentermine2341.9%
- 69Ozanimod1481.8%
- 70Deuruxolitinib11.8%
- 71Pretomanid111.7%
- 72Ublituximab591.6%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Multiple Sclerosis15 shared · 0.20
- Multiple Sclerosis Relapse16 shared · 0.20
- Paraesthesia28 shared · 0.15
- Muscular Weakness16 shared · 0.14
- Memory Impairment11 shared · 0.10
- Gait Disturbance26 shared · 0.10
- Balance Disorder7 shared · 0.07
- Mobility Decreased6 shared · 0.07
- Urinary Tract Infection12 shared · 0.06
- Pain In Extremity29 shared · 0.06
Literature
Recent PubMed references pinned to Hypesthesia as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Clinical Reasoning: A 55-Year-Old Man With Rapidly Progressive Weakness and Numbness.Neurology · 2026 · Li X, Remley W, Patel B, et al.PMID 42127357DOI 10.1212/WNL.0000000000218063
- 17-Year-Old Male Patient With Pulmonary TB Presenting With Tingling and Numbness in the Left Upper Limb.Chest · 2026 · Vyas YKPMID 41813304DOI 10.1016/j.chest.2025.09.125
- Peri-Incisional Numbness after Total Knee Arthroplasty: Prevalence, Evolution, and Impact on Functional Outcomes.Ortopedia, traumatologia, rehabilitacja · 2025 · Godoy Monzon D, Telesca P, Pascual Espinosa JM, et al.PMID 41729115DOI 10.5604/01.3001.0055.6436
- Early Postoperative Hypesthesia after Microvascular Decompression for Trigeminal Neuralgia is a Predictor of Long-Term Pain Relief: A Long-Term Cohort Study.World neurosurgery · 2026 · Roj B, Amante G, Prasad M, et al.PMID 41720263DOI 10.1016/j.wneu.2026.124880
- Early hyperaesthesia and late hypoaesthesia as manifestations of sensory neuropathy in dentistry - two case reports.Frontiers in endocrinology · 2026 · Lipták L, Lipták K, Kempler P, et al.PMID 41685245DOI 10.3389/fendo.2026.1741118
- Exploring new rehabilitation pathways for stroke based on the comorbidity of post-stroke hypoesthesia with anxiety and depression.PeerJ · 2026 · Chen Y, Zhao Y, Wu B, et al.PMID 41630843DOI 10.7717/peerj.20679
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.